Litigation should not be the strategy to achieve Star Rating reform. It is the alarm, not the repair.

The problem isn’t legalization. It’s how we’ve chosen to legalize: by defaulting to a kind of Wild West capitalism that ...

The agency has failed to consider ways in which industry influence can shape the patient voices that the FDA hears.

If states, including California, proceed with a penalty scaled to the full spending gap, they should recognize that they are essentially setting a global budget—and that effective global budgets need ...

It’s worth taking the time to institute practices that ensure this money is used in ways that honor the tens of thousands of ...

Addiction science has produced practical, life-saving knowledge because federal research has been guided by rigorous peer ...

Addressing the physician and nurse shortages will require both upstream interventions that build a shared health career pipeline and downstream investments that expand the distinct training capacities ...

Housing First has a strong and extensive evidence base demonstrating that it improves housing stability. Findings on health outcomes and costs are mixed, although it is not clear whether this reflects ...

Despite a lack of evidence of clinical benefit and substantial safety and quality concerns, an FDA advisory committee narrowly supported adding seven peptide substances to the pharmacy compounding ...

What California chooses in the next six months will determine whether a decade of Medicaid transformation holds or collapses and how the health and well-being of thousands or millions of California’s ...

Responding to patient-initiated portal messages is a growing source of work for physicians, yet little is known about how these messages are distributed across patients and physicians. Understanding ...

In 2001 the Centers for Medicare and Medicaid Services (CMS) allowed states to opt out of the requirement for reimbursement that a surgeon or anesthesiologist oversee the provision of anesthesia by ...